<--- Back to Details
First PageDocument Content
Immune system / Alternative complement pathway / Humoral immunity / Anaphylatoxin / Complement component 3 / Classical complement pathway / Complement receptor / Chemotaxis / Opsonin / Biology / Complement system / Anatomy
Immune system
Alternative complement pathway
Humoral immunity
Anaphylatoxin
Complement component 3
Classical complement pathway
Complement receptor
Chemotaxis
Opsonin
Biology
Complement system
Anatomy

JOURNAL OF VIROLOGY, June 2009, p. 5648–[removed]538X/09/$08.00⫹0 doi:[removed]JVI[removed]Copyright © 2009, American Society for Microbiology. All Rights Reserved. Vol. 83, No. 11

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 818,28 KB

Share Document on Facebook

Similar Documents

Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth

Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth

DocID: 1r05x - View Document

Helsinki Biomedical Dissertations No. 58  Complement Evasion by Borrelia burgdorferi Spirochetes Antti Alitalo

Helsinki Biomedical Dissertations No. 58 Complement Evasion by Borrelia burgdorferi Spirochetes Antti Alitalo

DocID: 102q2 - View Document

HK J Paediatr (new series) 2002;7:[removed]Feature Article The Role of Mannose-Binding Lectin in Health and Disease MW TURNER

HK J Paediatr (new series) 2002;7:[removed]Feature Article The Role of Mannose-Binding Lectin in Health and Disease MW TURNER

DocID: Vafq - View Document

© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology  REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris

© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology REVIEW Complement-targeted therapeutics Daniel Ricklin & John D Lambris

DocID: QbAx - View Document

ALN-CC5, an Investigational RNAi Therapeutic Targeting C5 for Complement Inhibition Anna Borodovsky1; Kristina Yucius1; Andrew Sprague1; Nirmal K. Banda2; V. Michael Holers2; Akshay Vaishnaw1; Martin Maier1; Rajeev Kalla

ALN-CC5, an Investigational RNAi Therapeutic Targeting C5 for Complement Inhibition Anna Borodovsky1; Kristina Yucius1; Andrew Sprague1; Nirmal K. Banda2; V. Michael Holers2; Akshay Vaishnaw1; Martin Maier1; Rajeev Kalla

DocID: NNEW - View Document